DK1781631T3 - Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf - Google Patents

Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf

Info

Publication number: DK1781631T3
Authority: DK; Denmark
Prior art keywords: diarylmethylpiperazine; preparations; derivatives; applications; diarylmethylpiperazine derivatives
Prior art date: 2004-08-02

Application number

DK05762524.6T

Other languages

English (en)

Inventor

William Brown

Andrew Griffin

Thomas Hudzik

Carla Maciag

Gennady Smagin

Christopher Walpole

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-02

Filing date

2005-07-27

Publication date

2012-05-14

2004-08-02 Priority claimed from SE0401968A external-priority patent/SE0401968D0/xx

2005-07-27 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2012-05-14 Application granted granted Critical

2012-05-14 Publication of DK1781631T3 publication Critical patent/DK1781631T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK05762524.6T 2004-08-02 2005-07-27 Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf DK1781631T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0401968A SE0401968D0 (sv)	2004-08-02	2004-08-02	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US60236304P	2004-08-18	2004-08-18
PCT/SE2005/001186 WO2006014133A1 (en)	2004-08-02	2005-07-27	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof

Publications (1)

Publication Number	Publication Date
DK1781631T3 true DK1781631T3 (da)	2012-05-14

Family

ID=35787371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05762524.6T DK1781631T3 (da)	2004-08-02	2005-07-27	Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf

Country Status (10)

Country	Link
US (2)	US8129393B2 (da)
KR (1)	KR101234421B1 (da)
CY (1)	CY1112717T1 (da)
DK (1)	DK1781631T3 (da)
HR (1)	HRP20120343T1 (da)
IL (1)	IL180544A (da)
MX (1)	MX2007001240A (da)
MY (1)	MY145425A (da)
NO (1)	NO20071096L (da)
UY (1)	UY29043A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1395567E (pt)	2001-05-18	2009-03-26	Astrazeneca Ab	Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
SE0203303D0 (sv) *	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH583713A5 (da)	1973-06-29	1977-01-14	Cermol Sa
DE2900810A1 (de)	1979-01-11	1980-07-24	Cassella Ag	Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
IT1140978B (it)	1980-05-23	1986-10-10	Selvi & C Spa	1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
GB8320701D0 (en)	1983-08-01	1983-09-01	Wellcome Found	Chemotherapeutic agent
IT1196150B (it)	1984-06-19	1988-11-10	Poli Ind Chimica Spa	Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono
SE8500573D0 (sv)	1985-02-08	1985-02-08	Ferrosan Ab	Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US5028610A (en)	1987-03-18	1991-07-02	Sankyo Company Limited	N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4829065A (en)	1987-04-24	1989-05-09	Syntex Pharmaceuticals, Ltd.	Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4826844A (en)	1987-09-30	1989-05-02	American Home Products Corporation	Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
US5840896A (en)	1989-11-22	1998-11-24	Janssen Pharmaceutica, N.V.	Method of preventing or limiting reperfusion damage
WO1991007967A2 (en)	1989-11-22	1991-06-13	Janssen Pharmaceutica N.V.	Method of preventing or limiting reperfusion damage
FI930860A7 (fi)	1990-08-29	1993-02-25	Upjohn Co	Tropolonijohdoksia ja niiden farmaseuttisia koostumuksia iskeemisten s airauksien ehkäisemiseen ja hoitamiseen
MY108616A (en)	1990-10-10	1996-10-31	Schering Corp	Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines of piperazines, and compositions and methods of use thereof
US5985880A (en)	1996-06-05	1999-11-16	Delta Pharmaceuticals	Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US5807858A (en)	1996-06-05	1998-09-15	Delta Pharmaceutical, Inc.	Compositions and methods for reducing respiratory depression
US5574159A (en)	1992-02-03	1996-11-12	Delta Pharmaceuticals, Inc.	Opioid compounds and methods for making therefor
GB9202238D0 (en)	1992-02-03	1992-03-18	Wellcome Found	Compounds
US5681830A (en)	1992-02-03	1997-10-28	Delta Pharmaceuticals, Inc.	Opioid compounds
FR2696744B1 (fr)	1992-10-12	1994-12-30	Logeais Labor Jacques	Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
RU2124511C1 (ru)	1993-05-14	1999-01-10	Фармасьютикал Ко., Лтд	Производные пиперазина
EP0711289B1 (en)	1993-07-30	2000-08-23	Delta Pharmaceuticals, Inc.	Piperazine compounds used in therapy
JP3352184B2 (ja)	1993-11-12	2002-12-03	株式会社アズウェル	ピペラジン不飽和脂肪酸誘導体
IL117149A0 (en)	1995-02-23	1996-06-18	Schering Corp	Muscarinic antagonists
SE9504661D0 (sv)	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
TW548271B (en)	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv)	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
ATE306472T1 (de)	1997-12-24	2005-10-15	Ortho Mcneil Pharm Inc	(4)-(aryl(piperidin-4-yl) aminobenzamidderivate die an delta-opioid rezeptor binden
US6011035A (en)	1998-06-30	2000-01-04	Neuromed Technologies Inc.	Calcium channel blockers
SE9904674D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904675D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904673D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE0001209D0 (sv)	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
SE0101765D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101766D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
PT1395567E (pt) *	2001-05-18	2009-03-26	Astrazeneca Ab	Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
SE0103313D0 (sv)	2001-10-03	2001-10-03	Astrazeneca Ab	Novel compounds
CN1596113B (zh)	2001-10-29	2010-05-26	蒙特库克生物科学公司	δ受体激动剂化合物在制备治疗抑郁症的药物中的应用
US8476280B2 (en)	2002-05-09	2013-07-02	Versi Group, Llc	Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203302D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0300105D0 (sv)	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0400027D0 (sv)	2004-01-09	2004-01-09	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
SE0401968D0 (sv)	2004-08-02	2004-08-02	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
JP2008531683A (ja)	2005-02-28	2008-08-14	アストラゼネカ・アクチエボラーグ	ジアリールメチルピペラジン誘導体、その製造及びその使用

2005
- 2005-07-27 DK DK05762524.6T patent/DK1781631T3/da active
- 2005-07-27 HR HRP20120343TT patent/HRP20120343T1/hr unknown
- 2005-07-27 KR KR1020077002597A patent/KR101234421B1/ko not_active Expired - Fee Related
- 2005-07-27 MX MX2007001240A patent/MX2007001240A/es active IP Right Grant
- 2005-07-29 UY UY29043A patent/UY29043A1/es not_active Application Discontinuation
- 2005-07-29 MY MYPI20053538A patent/MY145425A/en unknown
2007
- 2007-01-04 IL IL180544A patent/IL180544A/en not_active IP Right Cessation
- 2007-02-27 NO NO20071096A patent/NO20071096L/no not_active Application Discontinuation
2009
- 2009-12-22 US US12/644,309 patent/US8129393B2/en not_active Expired - Fee Related
2012
- 2012-02-21 US US13/401,139 patent/US20120149717A1/en not_active Abandoned
- 2012-04-25 CY CY20121100390T patent/CY1112717T1/el unknown

Also Published As

Publication number	Publication date
MX2007001240A (es)	2007-03-23
CY1112717T1 (el)	2016-02-10
US20120149717A1 (en)	2012-06-14
NO20071096L (no)	2007-04-26
IL180544A (en)	2011-10-31
IL180544A0 (en)	2007-06-03
MY145425A (en)	2012-02-15
US8129393B2 (en)	2012-03-06
KR20070041732A (ko)	2007-04-19
HRP20120343T1 (hr)	2012-05-31
HK1102815A1 (en)	2007-12-07
US20100168130A1 (en)	2010-07-01
UY29043A1 (es)	2006-03-31
KR101234421B1 (ko)	2013-02-18

Publication	Publication Date	Title
DK2046715T5 (da)	2014-07-28	Substituerede 1,3-diphenylpropanderivater, præparater og anvendelser deraf
NO20052855D0 (no)	2005-06-13	Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
NO20053974D0 (no)	2005-08-25	Tienopyrimidinforbindelser og anvendelse derav.
DK1673349T3 (da)	2010-10-25	Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
NO20055018D0 (no)	2005-10-27	Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
EP1773878A4 (en)	2012-06-20	INSULINOLIGOMER JOINTS, FORMULATIONS AND APPLICATIONS THEREOF
IS8153A (is)	2005-11-28	Ónæmisbælandi efnasambönd og efnablöndur
NO20055246D0 (no)	2005-11-08	Heteroaromatisk pentasyklisk forbindelse og medisinsk anvendelse derav
DK1894567T3 (da)	2012-11-19	Ledsagende farmaceutiske midler og anvendelse deraf
DK2057153T3 (da)	2012-10-15	(3-aryl-piperazin-1-yl)-derivater af 6,7 dialkoxyquinazolin, 6,7- dialkoxyphtalazin og 6,7-dialkoxyisoquinolin
EP1784219A4 (en)	2010-02-17	STABILIZING FORMULATIONS
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
NO20054709D0 (no)	2005-10-13	Sammenfoyningssystem og anvendelse av dette
DK1737961T3 (da)	2013-08-05	Modificerede bouganin proteiner, cytotoxiner og fremgangsmåder og anvendelser deraf
DK1670769T3 (da)	2009-08-10	Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
IS8219A (is)	2006-01-04	Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
DK1601744T3 (da)	2012-08-20	Forgasningsapparat og fremgangsmåde
NO20054674L (no)	2005-12-13	Benzotiazolderivatforbindelser, preperater og anvendelser
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
DK1885716T3 (da)	2013-02-11	Thiazolderivater og anvendelse deraf
NO20053809D0 (no)	2005-08-12	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
DK1753725T3 (da)	2013-05-27	Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf.
DK1773829T3 (da)	2009-04-20	Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
DE602005020457D1 (de)	2010-05-20	Master-slave-flip-flop, trigger-flip-flop und zähler